Position in XENE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$22,206,444
New position
Shares Held
367,900
first reported quarter
Ownership
0.380%
of shares outstanding
% of Portfolio
4.85%
of 13F equity value
Holder Rank
#60
of 313 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Jones Hill Capital LP holds $379,449,729 across 26 Biotechnology names. XENE ranks #8 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
1,431,590 | $81,915,579 | |
| 2 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,089,701 | $28,571,960 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
52,545 | $28,214,037 | |
| 4 | BCAX |
Bicara Therapeutics Inc.
|
892,621 | $26,501,917 | |
| 5 | RLMD |
Relmada Therapeutics, Inc.
|
3,655,075 | $25,293,119 | |
| 6 | TRVI |
Trevi Therapeutics, Inc.
|
1,339,212 | $24,976,303 | |
| 7 | PHVS |
Pharvaris N.V.
|
677,879 | $23,441,055 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
This page
|
367,900 | $22,206,444 |
All Filings in XENE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,206,444 | 367,900 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||